Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03317470 · ClinicalTrials.gov registry record · Phase 1
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 96
- Enrollment target
NCT03317470: Completed Phase 1 study, sponsored by Washington University School of Medicine.
NCT03317470 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 96 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03317470, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 96 participants
- Enrollment target
Study Summary
The investigators aim to improve adherence to follow-up recommendations for an abnormal Pap and effectively reduce disparities in cervical cancer risk and disease among rural and low-income urban women.
Primary Outcome
-Will use weekly clinic schedules to track adherence rates
Interventions
- OTHER Basic needs survey
- BEHAVIORAL Life Navigator
- OTHER Follow-up survey
- OTHER Follow-up survey (phase II participants only)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2017-08-29 |
| Est. Completion | 2018-12-09 |
| Phase | Phase 1 |
What the finished NCT03317470 record still lists
NCT03317470 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% higher).
The record links to 0 conditions, and to 4 interventions - of which Basic needs survey is the first listed.
NCT03317470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03317470 about?
NCT03317470 is a clinical study titled "Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap". The investigators aim to improve adherence to follow-up recommendations for an abnormal Pap and effectively reduce disparities in cervical cancer risk and disease among rural and low-income urban women.
What is the current status of trial NCT03317470?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 96 participants. The study started on 2017-08-29. Estimated completion is 2018-12-09.
What interventions are being tested in trial NCT03317470?
The interventions under investigation include: Basic needs survey (OTHER), Life Navigator (BEHAVIORAL), Follow-up survey (OTHER), Follow-up survey (phase II participants only) (OTHER).
Who is sponsoring clinical trial NCT03317470?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03317470's enrollment target sits among peer trials
96 600th of 2000 higher than 1,391 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI